Partial Cystectomy for Atypical Isolated Recurrence of Ovarian Adenocarcinoma - A Case Report and Literature Review - Case Reports - Oncology · Hematology

Gynecologic Cancer

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Lancet Oncol.

Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P; SOLO2/ENGOT-Ov21 investigators

doi: 10.1016/

Gynecologic Cancer

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses

Gynecol Oncol.

Bogani G, Tagliabue E, Ditto A, Signorelli M, Martinelli F, Casarin J, Chiappa V, Dondi G, Leone Roberti Maggiore U, Scaffa C, Borghi C, Montanelli L, Lorusso D, Raspagliesi F

doi: 10.1016/j.ygyno.2017.07.139.

Genitourinary Cancer

Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer

Clin Genitourin Cancer.

Pagliarulo V, Ancona P, Petitti T, Salerno A, Spadavecchia R, Di Stasi S, Cormio L, Maurizio B, Carrieri G, Ditonno P

doi: 10.1016/j.clgc.2016.11.005.

Gastrointestinal Cancer

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer

J Surg Oncol.

Sho S, Court CM, Winograd P, Russell MM, Tomlinson JS

doi: 10.1002/jso.24781.

Breast CancerGastrointestinal CancerGynecologic Cancer

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

World J Surg Oncol.

Mori R, Futamura M, Morimitsu K, Saigo C, Miyazaki T, Yoshida K

doi: 10.1186/s12957-017-1185-5.

Gynecologic Cancer

Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion

J Natl Compr Canc Netw.

Randall M, Burgess K, Buckingham L, Usha L

doi: 10.6004/jnccn.2019.7378.

Breast CancerRadio-Oncology

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Lancet.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists

doi: 10.1016/

COMMENTED

Gynecologic Cancer

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

Cancer Biol Ther.

Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P

doi: 10.1080/15384047.2019.1685291.

Gynecologic Cancer

The diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study

BJOG.

Mahyuddin AP, Liu L, Zhao C, Narasimhan K, Salto-Tellez M, Pang BNK, Lim DGS, Annalamai L, Chan JKY, Lim TYK, Biswas A, Rice G, Razvi K, Choolani M

doi: 10.1111/

Related content

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses

Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

The diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study